Skip to main content
VCbacked
Log inGet Started

Liberate Medical

Crestwood, United States

Liberate Medical licenses a technology that is synchronized with a patient's breathing cycle.

$4.5M raised
Sep 2025
Venture - Series Unknown
BiotechnologyHealth CareMedicalMedical Device

Top Investors

National Science FoundationNewchip AcceleratorXLerateHealthU.S. Department of DefenseKeyhorse Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Liberate Medical

How much funding has Liberate Medical raised?
Liberate Medical has raised $4.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2025.
Who are Liberate Medical's investors?
Liberate Medical's investors include National Science Foundation, Newchip Accelerator, XLerateHealth, U.S. Department of Defense, Keyhorse Capital.
Where is Liberate Medical headquartered?
Liberate Medical is headquartered in Crestwood, United States.
What does Liberate Medical do?
Liberate Medical licenses a technology that is synchronized with a patient's breathing cycle.
What stage is Liberate Medical at?
Liberate Medical is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Liberate Medical — Funding & Investors." VCBacked, September 29, 2025, https://www.vcbacked.co/company/liberate-medical. Accessed June 3, 2026.
APA
VCBacked. (2025). Liberate Medical — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/liberate-medical
Wikipedia (cite web)
{{cite web |title=Liberate Medical — Funding & Investors |url=https://www.vcbacked.co/company/liberate-medical |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong